Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

People

Medicinal Chemistry Award To George Ellestad

April 24, 2006 | A version of this story appeared in Volume 84, Issue 17

George A. Ellestad, Adjunct Senior Research Scientist in the Department of Chemistry at Columbia University, has been awarded the Medicinal Chemistry Award by the ACS Division of Medicinal Chemistry. The award will be given on June 28 during the 30th National Medicinal Chemistry Symposium in Seattle.

Ellestad spent most of his career at Lederle Laboratories in Pearl River, N.Y., which later became Wyeth Pharmaceuticals. One of his primary contributions was the unraveling of the DNA cleavage chemistry and mechanism of action of the potent enediyne-containing antitumor agent calicheamicin.

His work on the structure and bioorganic chemistry of calicheamicin contributed to the development of Mylotarg for the treatment of relapsed myeloid leukemia. Ellestad was also involved in the search for a new tetracycline that led to the antibiotic Tigecycline.

Ellestad retired from Wyeth in 2004. His current research focuses on porphyrin-conjugated DNA to increase circular dichroism sensitivity for monitoring DNA conformational changes.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.